Laser-sclerosing foam hybrid treatment, a non-tumescent technique for insufficient great saphenous vein ablation

Phlebology. 2024 May;39(4):267-272. doi: 10.1177/02683555231226264. Epub 2024 Jan 5.

Abstract

Objective: We aim to report on the Laser-Sclerosing Foam Hybrid Treatment (LSFHT) and its outcomes when used on patients with great saphenous vein (GSV) insufficiency.

Methods: This was a single center retrospective cohort study on patients with GSV insufficiency that were treated with the LSFHT technique, a surgical procedure that comprises the use of both sclerosing foam and endovenous ablation and avoids the use of tumescent anesthesia. Occlusion rates and complications were reported.

Results: 139 legs from 106 patients were operated, achieving a 100% occlusion rate, while only a small burn and 2 popliteal vein thrombosis cases occurred.

Conclusion: The study suggests that the LSFHT is a feasible fast procedure that proved both effective and safe for the treatment of GSV insufficiency.

Keywords: Endovenous laser treatment; chronic venous insufficiency; endovenous thermal ablation; great saphenous vein; ultrasound-guided sclerotherapy.

MeSH terms

  • Humans
  • Laser Therapy* / adverse effects
  • Retrospective Studies
  • Saphenous Vein / surgery
  • Sclerotherapy / methods
  • Treatment Outcome
  • Varicose Veins* / surgery
  • Venous Insufficiency* / diagnostic imaging
  • Venous Insufficiency* / surgery